Stockscreener 앱 받기
0.44
12.09%
-0.0605
시간 외 거래:
.45
0.01
+2.27%
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
Aptevo Therapeutics announces common stock offering - Investing.com Australia
APVO’s latest rating updates from top analysts. - knoxdaily.com
Aptevo Therapeutics announces common stock offering By Investing.com - Investing.com India
Closing Bell Recap: Aptevo Therapeutics Inc (APVO) Ends at 0.61, Reflecting a -9.31 Downturn - DWinneX
Aptevo Therapeutics announces at-the-market offering - Investing.com Australia
APVO stock plunges to 52-week low, touches $0.59 - Investing.com
APVO stock plunges to 52-week low, touches $0.59 By Investing.com - Investing.com UK
Aptevo Therapeutics announces at-the-market offering By Investing.com - Investing.com India
SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow
Press Release Distribution & PR Platform - ACCESS Newswire
Applied Materials Q2 Earnings: Tech Giant's Financial Results Coming May 15 - Stock Titan
A look into Aptevo Therapeutics Inc (APVO)’s deeper side - Sete News
Aptevo Therapeutics Inc’s latest rating changes from various analysts - knoxdaily.com
Evogene (EVGN) Sees Dramatic Surge in Investor Interest Amid Strategic Moves | APVO Stock News - GuruFocus
Market Momentum: Aptevo Therapeutics Inc (APVO) Registers a 9.08 Increase, Closing at 0.69 - DWinneX
Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus
Aptevo Therapeutics Raises Fresh Capital: $2M Direct Offering to Advance Cancer Drug Pipeline - Stock Titan
Aptevo Therapeutics Inc (APVO) Shares Are Down -85.25% YTD - Marketing Sentinel
Aptevo Therapeutics announces $2 million stock offering By Investing.com - Investing.com South Africa
Aptevo Therapeutics $2.0 Million Registered Direct Offering Pric - GuruFocus
Aptevo Therapeutics (APVO) Secures $2M Through Registered Direct Offering | APVO Stock News - GuruFocus
Aptevo Therapeutics announces $2 million stock offering - Investing.com
Aptevo Therapeutics Raises Fresh Capital: $2M Boost for Revolutionary Cancer Treatment Development - Stock Titan
Aptevo Therapeutics Inc (APVO) Stock: Navigating a Year of Volatility - investchronicle.com
How does APVO’s price to cash per share ratio compare in the market? - uspostnews.com
Aptevo Therapeutics (APVO) Completes $2.1 Million Stock Offering - GuruFocus
Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Now Is A Good Time To Buy Aptevo Therapeutics Inc (NASDAQ: APVO) - Marketing Sentinel
APVO stock plunges to 52-week low, touches $0.94 By Investing.com - Investing.com South Africa
APVO stock plunges to 52-week low, touches $0.94 - Investing.com Australia
Alligator Bioscience and Aptevo Therapeutics to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types at ESMO Congress 2024 - ACCESS Newswire
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - Asianet Newsable
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Aptevo Secures Fresh $2.1M Capital: What This Means for Clinical Pipeline - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Aptevo (APVO) Sees Significant Market Rally After Equity Offering - Stocks Telegraph
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aptevo Therapeutics Launches $2.1 Million Registered Direct Offering; Shares Rise - MarketScreener
Aptevo Therapeutics (APVO) Announces $2.1 Million Securities Off - GuruFocus
0.39%
3.66%
자본화:
|
볼륨(24시간):